NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

9478	Companies
185489	Keywords
117869	Articles
99348	Press releases

Home
Companies
NanoViricides, Inc.

BRIEF

published on 04/29/2025 at 12:35, 7 months 6 days ago

Avancée potentielle dans le traitement de la rougeole : NanoViricides développe un médicament antiviral

NanoViricides NV-387 Médicament Antiviral Traitement De La Rougeole Maladie Endémique
BRIEF

published on 04/29/2025 at 12:35, 7 months 6 days ago

Potential Breakthrough in Measles Treatment: NanoViricides Develops Antiviral Drug

NanoViricides NV-387 Antiviral Drug Measles Treatment Endemic Disease
PRESS RELEASE

published on 04/29/2025 at 12:30, 7 months 6 days ago

Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It
NanoViricides, Inc. provides details on its Measles drug development program targeting the endemic potential of the virus in the USA and the effectiveness of their broad-spectrum antiviral drug NV-387

NV-387 NanoViricides Inc. Broad-spectrum Antiviral Measles Drug Development Vaccination Decline
BRIEF

published on 04/14/2025 at 12:35, 7 months 21 days ago

Growing Measles Threat Spurs NanoViricides to Test Antiviral Solution

Measles Outbreak NanoViricides NV-387 Antiviral Solution Viral Spread FDA Emergency Access
BRIEF

published on 04/14/2025 at 12:35, 7 months 21 days ago

La menace croissante de la rougeole incite NanoViricides à tester une solution antivirale

Épidémie De Rougeole NanoViricides NV-387 Solution Antivirale Propagation Virale Accès D'urgence À La FDA
PRESS RELEASE

published on 04/14/2025 at 12:30, 7 months 21 days ago

Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
NanoViricides, Inc. commences evaluation of clinical drug NV-387 for Measles virus treatment, utilizing innovative nanomedicine technology. Company aims to combat Measles outbreak and provide effective antiviral solution

NanoViricides NV-387 Antiviral Nanomedicine Measles
BRIEF

published on 03/11/2025 at 11:35, 8 months 25 days ago

NanoViricides voit un potentiel à long terme malgré la baisse des actions

NV-387 Bourse Essai De Phase II Médicaments Antiviraux Politiques Tarifaires
BRIEF

published on 03/11/2025 at 11:35, 8 months 25 days ago

NanoViricides Sees Long-Term Potential Amid Stock Decline

NV-387 Stock Market Antiviral Drugs Phase II Trial Tariff Policies
PRESS RELEASE

published on 03/11/2025 at 11:30, 8 months 25 days ago

NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
NanoViricides, Inc. declares its business is not affected by US tariff policies or spending cuts, focusing on developing broad-spectrum antiviral drugs. The company's NV-387 shows potential for treating measles

NanoViricides NV-387 Antiviral Drugs Measles Treatment Pandemic Solutions
BRIEF

published on 03/04/2025 at 12:35, 9 months 1 day ago

Measles Crisis: NanoViricides Proposes NV-387 as Potential Solution

NV-387 Public Health Clinical Trials Antiviral Treatment Measles Outbreak

Accesswire

Published on 12/05/2025 at 16:00, 28 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 43 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 43 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 53 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 1 hour 3 minutes ago

Usha Resources Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:10, 18 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 28 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 28 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 28 minutes ago

Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 28 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 17 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 17 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 30 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 43 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 43 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE